Ascendis Pharma A/S: H.C. Wainwright cuts target price to $335 from $344
ASND•H.C. Wainwright cut its target price for Ascendis Pharma A/S to $335 from $344.
ASND•ASND•ASND•H.C. Wainwright cut its target price for Ascendis Pharma A/S to $335 from $344.
